Novolog (Pharm-Up 1966) Ltd (NVLG.TA)

ILA 181.1

(0.39%)

Total Liabilities Summary of Novolog (Pharm-Up 1966) Ltd

Novolog (Pharm-Up 1966) Ltd's latest annual total liabilities in 2023 was 2.39 Billion ILS , up 21.29% from previous year.
Novolog (Pharm-Up 1966) Ltd's latest quarterly total liabilities in 2024 Q2 was 2.43 Billion ILS , up 2.0% from previous quarter.
Novolog (Pharm-Up 1966) Ltd reported annual total liabilities of 1.97 Billion ILS in 2022, up 6.15% from previous year.
Novolog (Pharm-Up 1966) Ltd reported annual total liabilities of 1.85 Billion ILS in 2021, down -1.73% from previous year.
Novolog (Pharm-Up 1966) Ltd reported quarterly total liabilities of 2.38 Billion ILS for 2024 Q1, down -0.3% from previous quarter.
Novolog (Pharm-Up 1966) Ltd reported quarterly total liabilities of 2.52 Billion ILS for 2023 Q3, up 4.64% from previous quarter.

Annual Total Liabilities Chart of Novolog (Pharm-Up 1966) Ltd (2023 - 2014)

Historical Annual Total Liabilities of Novolog (Pharm-Up 1966) Ltd (2023 - 2014)

Year	Total Liabilities	Total Liabilities Growth
2023	2.39 Billion ILS	21.29%
2022	1.97 Billion ILS	6.15%
2021	1.85 Billion ILS	-1.73%
2020	1.89 Billion ILS	0.23%
2019	1.88 Billion ILS	15.7%
2018	1.63 Billion ILS	-5.22%
2017	1.72 Billion ILS	18.42%
2016	1.45 Billion ILS	-5.48%
2015	1.53 Billion ILS	24.78%
2014	1.23 Billion ILS	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	2.43 Billion ILS	2.0%
2024 Q1	2.38 Billion ILS	-0.3%
2023 Q3	2.52 Billion ILS	4.64%
2023 Q2	2.41 Billion ILS	14.63%
2023 Q1	2.1 Billion ILS	6.9%
2023 FY	2.39 Billion ILS	21.29%
2023 Q4	2.39 Billion ILS	-5.41%
2022 Q4	1.97 Billion ILS	-17.07%
2022 FY	1.97 Billion ILS	6.15%
2022 Q2	2.15 Billion ILS	9.06%
2022 Q1	1.97 Billion ILS	6.34%
2022 Q3	2.37 Billion ILS	10.36%
2021 Q3	2.16 Billion ILS	5.96%
2021 Q2	2.04 Billion ILS	5.05%
2021 FY	1.85 Billion ILS	-1.73%
2021 Q1	1.94 Billion ILS	2.87%
2021 Q4	1.85 Billion ILS	-14.18%
2020 Q1	2.01 Billion ILS	6.89%
2020 Q3	2.21 Billion ILS	3.54%
2020 Q2	2.14 Billion ILS	6.26%
2020 FY	1.89 Billion ILS	0.23%
2020 Q4	1.89 Billion ILS	-14.77%
2019 Q1	2.07 Billion ILS	27.44%
2019 FY	1.88 Billion ILS	15.7%
2019 Q4	1.88 Billion ILS	-14.84%
2019 Q3	2.21 Billion ILS	4.23%
2019 Q2	2.12 Billion ILS	2.29%
2018 Q4	1.63 Billion ILS	-6.33%
2018 FY	1.63 Billion ILS	-5.22%
2018 Q1	1.73 Billion ILS	1.14%
2018 Q2	1.76 Billion ILS	1.54%
2018 Q3	1.74 Billion ILS	-1.47%
2017 Q2	1.51 Billion ILS	1.51%
2017 Q1	1.49 Billion ILS	2.63%
2017 Q3	1.71 Billion ILS	13.47%
2017 Q4	1.72 Billion ILS	0.17%
2017 FY	1.72 Billion ILS	18.42%
2016 Q1	- ILS	-100.0%
2016 FY	1.45 Billion ILS	-5.48%
2016 Q4	1.45 Billion ILS	-8.3%
2016 Q3	1.58 Billion ILS	0.0%
2015 Q4	1.53 Billion ILS	0.0%
2015 FY	1.53 Billion ILS	24.78%
2014 FY	1.23 Billion ILS	0.0%

Peer Total Liabilities Comparison of Novolog (Pharm-Up 1966) Ltd

Name	Total Liabilities	Total Liabilities Difference